Omadacycline Stocks List
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
GERM | C | ETFMG Treatments Testing and Advancements ETF | 3.25 | |
BBP | D | BioShares Biotechnology Products Fund | 1.09 | |
SBIO | D | ALPS Medical Breakthroughs ETF | 1.06 | |
PGJ | B | PowerShares Golden Dragon China Portfolio | 0.45 | |
EVNT | D | AltShares Event-Driven ETF | 0.43 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Apr 30 | ZLAB | Zai Lab Limited's (NASDAQ:ZLAB) Profit Outlook |
Related Industries:
Biotechnology
- Omadacycline
Omadacycline, sold under the brand name Nuzyra, is a broad spectrum antibiotic medication belonging to the aminomethylcycline subclass of tetracycline antibiotics. In the United States, it was approved in October 2018, for the treatment of community-acquired bacterial pneumonia and acute skin and skin structure infections.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles